Usha Chakravarthy (U Chakravarthy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Eye (London, England)

Journal of clinical medicine

The British journal of ophthalmology

Health technology assessment (Winchester, England)

Queen's University Belfast

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen's University Belfast Aug 1o 1999

United Kingdom

Professor :: Center for Vision Science

Publications

Stela Vujosevic, Camilla Alovisi, Usha Chakravarthy
Epidemiology of geographic atrophy and its precursor features of intermediate age-related macular degeneration. Acta ophthalmologica 101 (8) (2023)
Luping Wang, Wei Wang, Zhuohua Zhou, Hao Wang, Usha Chakravarthy, Tunde Peto, Giuseppe Casalino, Kang Wang, Shuang Li
Quantitative Assessment of Choroidal Thickness and Choroidal Vascular Features in Healthy Eyes Based on Image Binarization of EDI-OCT: A Single-Center Cross-Sectional Analysis in Chinese Population. Journal of clinical medicine 12 (5) (2023)
Luping Wang, Wei Wang, Zhuohua Zhou, Hao Wang, Usha Chakravarthy, Tunde Peto, Giuseppe Casalino, Kang Wang, Shuang Li
Quantitative Assessment of Choroidal Thickness and Choroidal Vascular Features in Healthy Eyes Based on Image Binarization of EDI-OCT: A Single-Center Cross-Sectional Analysis in Chinese Population. Journal of clinical medicine 12 (5) (2023)
Ruth E Hogg, David M Wright, Nicola B Quinn, Katherine Alyson Muldrew, Barbra Hamill, Laura Smyth, Amy Jayne McKnight, Jayne Woodside, Mark A Tully, Sharon Cruise, Bernadette McGuinness, Ian S Young, Frank Kee, Tunde Peto, Usha Chakravarthy
Prevalence and risk factors for age-related macular degeneration in a population-based cohort study of older adults in Northern Ireland using multimodal imaging: NICOLA Study. The British journal of ophthalmology (2022)
Isabella D Baur, Tunde Peto, Frank Koch, Simon R Taylor, João Paulo Castro de Sousa, Lauren Hill, Clare Bailey, Usha Chakravarthy, null null
Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study. The British journal of ophthalmology (2022)
Katie Banister, Jonathan Alistair Cook, Graham S Scotland, Augusto Azuara-Blanco, Beatriz Goulao, Heinrich Heimann, Rodolfo Hernández, Ruth E Hogg, Charlotte Kennedy, Sobha Sivaprasad, Craig R Ramsay, Usha Chakravarthy
Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study. Health technology assessment (Winchester, England) 26 (8) (2022)
Usha Chakravarthy, Beatriz G Armendariz, Sascha Fauser
15 years of anti-VEGF treatment for nAMD: success or failure or something in between? Eye (London, England) 36 (12) (2022)
Richard Gale, Oliver Cox, Craig Keenan, Usha Chakravarthy
Health technology assessment of new retinal treatments; the need to capture healthcare capacity issues. Eye (London, England) 36 (12) (2022)
Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Francesco Maria Bandello, Baruch D Kuppermann, Anat Loewenstein, Carl D Regillo, Usha Chakravarthy
Terms non-exudative and non-neovascular: awaiting entry at the doors of AMD reclassification. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 259 (6) (2021)
Usha Chakravarthy, Moshe Havilio, Annie Syntosi, Natasha Pillai, Emily Wilkes, Gidi Benyamini, Catherine Best, Alexandros Sagkriotis
Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. Eye (London, England) 35 (11) (2021)
Philip Hykin, Andrew Toby Prevost, Sobha Sivaprasad, Joana C Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Rebekah Pennington, Barry Hounsome, Ellen Lever, Andrew Metry, Edith Poku, Yit C Yang, Simon Peter Harding, Andrew John Lotery, Usha Chakravarthy, John E Brazier
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health technology assessment (Winchester, England) 25 (38) (2021)
Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, Baruch D Kuppermann, Anat Loewenstein, Carl D Regillo, Usha Chakravarthy
Vortex vein anastomosis and pachychoroid-an evolving understanding. Eye (London, England) 35 (6) (2021)
Clare Bailey, Usha Chakravarthy, Andrew John Lotery, Geeta Menon, James Stephen Talks, null null
Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study. Eye (London, England) (2021)
James Stephen Talks, Irene M Stratton, Tunde Peto, Andrew John Lotery, Usha Chakravarthy, H Eleftheriadis, S Izadi, N Dhingra, Peter Henry Scanlon, null null
Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years. Eye (London, England) (2021)
Monika Fleckenstein, Tiarnan D L Keenan, Robyn H Guymer, Usha Chakravarthy, Steffen Schmitz-Valckenberg, Caroline C Klaver, Wai T Wong, Emily Y Chew
Age-related macular degeneration. Nature reviews. Disease primers 7 (1) (2021)
Usha Chakravarthy, Ian Pearce, Sanjiv Banerjee, Benjamin J L Burton, Louise Downey, Richard Gale, Jignesh Patel, Sudeshna Patra, Sobha Sivaprasad, Michael Stevenson, Susanne Lupton
Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema. BMJ open ophthalmology 4 (1) (2019)

Usha Chakravarthy.css-eqlu8i{font-size:small;padding-left:4px;} (U Chakravarthy)

Publication Activity (10 Years)

Top Topics

Top Venues

Usha Chakravarthy (U Chakravarthy)